Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
4484
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
||
|
NDF-RT |
N0000184169
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
||
|
WHO-VATC |
QB02BD07
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
||
|
WHO-ATC |
B02BD07
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
N0000175979
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | Increased Coagulation Activity [PE] | ||
|
100000124487
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | |||
|
SUB13818MIG
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | |||
|
N0000168159
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | Transglutaminases [Chemical/Ingredient] | ||
|
1091605
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | |||
|
D005176
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | |||
|
C200601
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | |||
|
F7R0FBC1XD
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | |||
|
9013-56-3
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | |||
|
4271
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
ALTERNATIVE | RxNorm | ||
|
m5237
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | |||
|
F7R0FBC1XD
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | |||
|
N0000007914
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | Blood Coagulation Factors [Chemical/Ingredient] | ||
|
N0000184155
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY | Increased Fibrin Polymerization Activity [PE] | ||
|
DB12909
Created by
admin on Sat Dec 16 00:28:36 UTC 2023 , Edited by admin on Sat Dec 16 00:28:36 UTC 2023
|
PRIMARY |
ACTIVE MOIETY